Details for New Drug Application (NDA): 013026
✉ Email this page to a colleague
NDA 013026 describes TRECATOR, which is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the TRECATOR profile page.
The generic ingredient in TRECATOR is ethionamide. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ethionamide profile page.
The generic ingredient in TRECATOR is ethionamide. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ethionamide profile page.
Summary for 013026
| Tradename: | TRECATOR |
| Applicant: | Wyeth Pharms |
| Ingredient: | ethionamide |
| Patents: | 0 |
Suppliers and Packaging for NDA: 013026
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TRECATOR | ethionamide | TABLET;ORAL | 013026 | NDA | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0008-4117 | 0008-4117-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0008-4117-01) |
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
